Patent ID: 11925487
Assignee: FIFTH EYE INC.
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 9:
10. A method for the continuous monitoring of a hemodynamic condition of a patient, the method comprising:
receiving an electrocardiogram (ECG) signal stream at a first location;
transmitting the ECG signal stream to a second location;
with a set of training data comprising data from healthy and sick patients, training a model to predict a physiological condition for the patient;
at the second location, determining a set of labels for the hemodynamic condition, wherein determining the set of labels comprises, automatically, and at least in part with the trained model:
determining a set of waveform features of the ECG signal stream;
determining a patient-specific waveform morphology metric based on the set of waveform features;
checking the ECG signal stream for a first and second set of data criteria;
determining a set of hemodynamic stability values based on the patient-specific waveform morphology metric, wherein the hemodynamic stability values comprise a predicted time until hemodynamic instability; and
determining the set of labels, indicating the hemodynamic condition of the patient, based on the set of hemodynamic stability values, wherein when any of the first set of data criteria are satisfied, a corresponding label of the set of labels indicates that data is missing from the ECG signal stream, and wherein when any of the second set of data criteria are satisfied, a corresponding label for the set of labels indicates that the signal stream is noisy;

displaying a visual graphic based on the set of labels at a display located at a healthcare facility associated with the patient;
determining a treatment for the patient based on the set of labels, wherein the treatment is initiated by a healthcare provider;
determining a second set of labels for the hemodynamic condition after the treatment is initiated, wherein a success of the treatment is determined based on the second set of labels;
continuously updating the predicted time until hemodynamic instability, thereby enabling the continuous monitoring of the patient and an adjustment in the treatment;
determining a risk classification based on at least one of the first set of labels or the second set of labels; and
in response to determining the risk classification, automatically initiating administration of a drug delivery to the patient at a therapeutic delivery system, wherein the therapeutic delivery system comprises at least one of: a smart pump, a smart infusion system, or an automated drug delivery system.